Description: Certara Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software and technology to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. The company serves biopharmaceutical companies and academic institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, and Australia. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
Home Page: www.certara.com
CERT Technical Analysis
100 Overlook Center
Princeton,
NJ
08540
United States
Phone:
609 716 7900
Officers
| Name | Title |
|---|---|
| Dr. William F. Feehery Ph.D. | CEO & Director |
| Mr. M. Andrew Schemick | Chief Financial Officer |
| Mr. Leif E. Pedersen | Pres of Software |
| Dr. Robert P. Aspbury Ph.D. | Pres of Simcyp Division |
| Mr. Andrew Schemick | Chief Financial Officer |
| Prof. Amin Rostami PharmD, Ph.D., FCP | Chief Scientific Officer |
| Mr. Richard M. Traynor | Sr. VP, Gen. Counsel & Sec. |
| Mr. Ron DiSantis | Sr. VP of Corp. Devel. |
| Ms. Nicolette D. Sherman | Chief HR Officer |
| Mr. Jaap Mandema | Chief Innovation Officer |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 33.4448 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.4654 |
| Price-to-Sales TTM: | 8.0733 |
| IPO Date: | 2020-12-11 |
| Fiscal Year End: | December |
| Full Time Employees: | 1054 |